Key takeaways
The current Terms of Use explicitly exclude the EU, UK and EEA.
Canada, Australia, Switzerland and other countries should not be labelled supported solely because they are outside those regions.
Registration asks for an NPI or, where applicable, another professional licensing number; that does not guarantee approval in every country.
The privacy policy explains data transfers, while the terms establish geographic restrictions.
Current availability signals
Professional account verification
United States
The registration terms request professional information and an NPI or another applicable licensing number. OpenEvidence may verify that information and decline an account.
Explicitly excluded
United Kingdom
UK access is excluded in the September 17 terms, regardless of EU membership.
Explicitly excluded
European Union
This includes France, Spain, Italy and the other EU member states. The source is the current geographic restriction in the terms.
Explicitly excluded
Other EEA countries
The EEA restriction also covers Norway, Iceland and Liechtenstein. It should not be described as an EU-only restriction.
Eligibility not confirmed here
Canada, Australia and Switzerland
These countries are not named in that regional exclusion. This is not confirmation that registration, every feature, or institutional use is supported.
Confirm with the vendor
Other countries
The terms also exclude US-embargoed countries and reserve the right to limit geographic access. No complete supported-country list was identified in the reviewed documents.
Can I register without a US NPI?
The account-registration section mentions an NPI or another applicable professional licensing number. It also asks for your profession and specialty and allows verification or refusal of an account. A non-US licence is therefore a question to confirm through the official registration process, not proof of worldwide eligibility.
- •Check the official sign-up flow for your country and professional role.
- •Use accurate credentials; do not substitute someone else’s identifier.
- •Ask OpenEvidence which features your country and account type support.
What “not available in your country” means
In the EU, UK and EEA, the vendor’s current terms explicitly exclude access. An existing account, travel history, or a VPN does not change that restriction. Elsewhere, a failed login alone cannot distinguish country eligibility, credential verification, and an account problem; ask the vendor to confirm.
What changed in the policy evidence
The current primary source is the September 17, 2026 Terms of Use. The privacy policy revised on the same day discusses transfers to the US and other jurisdictions; it no longer contains the earlier wording about users in countries with stricter privacy laws. We therefore use the terms for access status and the privacy policy for data handling.
- •Do not infer worldwide access from the removal of older privacy wording.
- •Do not infer a global block from the named EU, UK and EEA restrictions.
- •The terms also address providing clinical guidance to people in excluded regions, so check the intended use as well as your own location.
How to compare an alternative in your country
Ask each vendor about your country, professional role, and intended workflow before comparing features. A supported account and an appropriate organisational agreement are separate from whether a product can produce a useful cited answer.
- •For Vera Health, review the local sign-up process and the published data processing agreement.
- •For UpToDate, check your institutional access or individual licence and which AI features it includes.
- •For DynaMed or Dyna AI, confirm the exact regional product; the EU-facing page does not establish access everywhere.
- •Compare original-source links, local guideline coverage, language, and total subscription cost using the same non-identifying examples.